EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for IRWD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.7668
March 31, 2026 0.5974
December 31, 2025 0.1206
September 30, 2025 0.1487
June 30, 2025 -0.0579
March 31, 2025 -0.2007
December 31, 2024 0.0051
September 30, 2024 -0.016
June 30, 2024 0.0432
March 31, 2024 -6.788
December 31, 2023 -6.511
September 30, 2023 -6.240
June 30, 2023 -6.043
March 31, 2023 1.000
December 31, 2022 0.954
September 30, 2022 0.9399
June 30, 2022 0.9991
March 31, 2022 3.186
December 31, 2021 3.227
September 30, 2021 3.245
June 30, 2021 3.122
March 31, 2021 0.8858
December 31, 2020 0.6608
September 30, 2020 0.6964
June 30, 2020 0.6136
Date Value
March 31, 2020 0.5348
December 31, 2019 0.1313
September 30, 2019 -0.2723
June 30, 2019 -1.542
March 31, 2019 -1.946
December 31, 2018 -1.853
September 30, 2018 -1.672
June 30, 2018 -0.7545
March 31, 2018 -0.73
December 31, 2017 -0.80
September 30, 2017 -0.97
June 30, 2017 -0.98
March 31, 2017 -0.83
December 31, 2016 -0.56
September 30, 2016 -0.5683
June 30, 2016 -0.6683
March 31, 2016 -0.8583
December 31, 2015 -1.008
September 30, 2015 -1.18
June 30, 2015 -1.15
March 31, 2015 -1.25
December 31, 2014 -1.39
September 30, 2014 -1.55
June 30, 2014 -1.76
March 31, 2014 -1.89

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
AbbVie, Inc. 3.537
Rigel Pharmaceuticals, Inc. 16.32
Marker Therapeutics, Inc. -0.4807
Verastem, Inc. -2.46
Theriva Biologics, Inc. -0.6688